Studies have shown that people with high levels of omega-3s are better protected against serious COVID-19 infections.

Published Date: 02 Mar 2023

A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .

Read Full News

Latest News

Spain Informs WHO of Possible Human Swine Flu Case

Spain has informed the World Health Organization of a possible infection with the swine flu virus that may have been transmitted between humans, a health official said on Friday.

Bird Flu Devastates 7.4 Million Pennsylvania Chickens in a Month

Bird flu has wiped out 7.4 million chickens in Pennsylvania in the past month, a swift and devastating loss that veterinarians and industry members suspect ⁠may be linked to...

CDC Acting Director Bhattacharya Urges Use of Measles Vaccine

The U.S. Centers for Disease Control and Prevention's new acting director, Jay Bhattacharya, on Monday urged Americans to get vaccinated against ⁠measles, saying it was the...

Longevity Research Is a Public Health Imperative: Barzilai

From healthcare costs to cancer survival and even space travel, Nir Barzilai explains why targeting aging is crucial for our entire society.

Africa CDC Cites Concerns Over Data Sharing in US Health Deals

There are big issues in health funding deals the US is pursuing with African countries, the head of the African CDC said Thursday.

U.S. Surgeon General Nominee Means Says She Backs Vaccines, With Parental Conversations

Casey Means, President ⁠Donald Trump's nominee for U.S. ⁠surgeon general and an ally of ⁠Health Secretary ‌Robert F. Kennedy Jr., said before the Senate's Health, Education,...

Todays Updates

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Todays Updates

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Latest News

Spain has informed the World Health Organization of a possible infection with the swine flu virus that may have been transmitted between humans, a health official said on Friday.

Bird flu has wiped out 7.4 million chickens in Pennsylvania in the past month, a swift and devastating loss that veterinarians and industry members suspect ⁠may be linked to...

The U.S. Centers for Disease Control and Prevention's new acting director, Jay Bhattacharya, on Monday urged Americans to get vaccinated against ⁠measles, saying it was the...

From healthcare costs to cancer survival and even space travel, Nir Barzilai explains why targeting aging is crucial for our entire society.

There are big issues in health funding deals the US is pursuing with African countries, the head of the African CDC said Thursday.

Casey Means, President ⁠Donald Trump's nominee for U.S. ⁠surgeon general and an ally of ⁠Health Secretary ‌Robert F. Kennedy Jr., said before the Senate's Health, Education,...

News All Time

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...

AAP Finds No New Evidence Against Hep B Vaccine Birth Dose

AAP publishes review of safety and efficacy of hepatitis B vaccination birth dose.

Healthy Life Expectancy Declines Again

Years spent in good health have dropped to their lowest level since comparable data were first collected in 2011 to 2013, with stark regional gaps across the UK.

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to faster linkage to antiretroviral therapy among people with HIV infection.

Long-Acting HIV Therapy May Be Safe After HBV Exposure

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Cancer Screening Gaps Leave People With HIV at Elevated Risk

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

ED Screening Uncovers Elevated Risk for Cervical Cancer

Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.

Pritelivir Shows Promise for HSV

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

STI Prevention With Doxycycline Raises Resistance Fears

Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.

Gaps in Primary Care Affect Transgender Health in Spain

Data from more than 1800 participants outlines structural barriers, high mental health diagnoses, and uneven access to gender-affirming and preventive services.

AAS Misuse Damages Heart, Liver, Kidneys, and Brain

Supraphysiologic anabolic steroid use is increasing among recreational athletes, causing cardiac, psychiatric, renal, and reproductive complications.

Use of Opioid Combinations Tied to Impaired Cognition in HIV

The use of opioids alone does not significantly impair cognition in patients with HIV infection, but the combined use of opioids and antidepressants is linked to poorer neurocognitive performance.

Four States and New York City Join WHO Outbreak Network

After United States’ withdrawal from the WHO, four states and New York City have partnered with the WHO to maintain access to international outbreak intelligence and strengthen preparedness efforts.

Zimbabwe Rolls Out New HIV Prevention Drug Lenacapavir

Zimbabwe's health authorities begin administering the long-acting HIV prevention drug lenacapavir, making ⁠the country one of the first globally to roll it out.

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Trial evaluates a vitamin B3 derivative in people with long COVID

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...